A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer
Clinical trial NCT07777211 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07777211
- Sponsor
- Beijing Gene Key Life Technology Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-14
- Primary completion
- 2027-03-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.